Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TheraCour Pharma
West Haven, Connecticut, United Statestheracour.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
TheraCour’s technology underpins several clinical candidates, including nanomedicine antivirals that have completed Phase 1 human trials for enveloped viral infections such as COVID-19 and herpesviruses; most programs are preclinical or IND-enabling, with ongoing advancement toward Phase 2 in lead candidates via licensee companies.[1][2][4]
- Therapeutic areas
- Infectious Diseases
- Modalities
- Small moleculeNanoparticleNanomedicine
- Industry
- Biotech
02
Partnerships
NanoViricides (exclusive field licensee for human antiviral therapeutics)AllExcel (technology licensor)
Beyond the preview
Go deeper on TheraCour Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TheraCour Pharma.